Related references
Note: Only part of the references are listed.Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
Da Yang et al.
CANCER CELL (2013)
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
Sergio Marchini et al.
EUROPEAN JOURNAL OF CANCER (2013)
TGF-beta upregulates miR-181a expression to promote breast cancer metastasis
Molly A. Taylor et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit
X. Li et al.
CELL DEATH AND DIFFERENTIATION (2012)
The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer
Shogo Yamamura et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer
L. Cao et al.
ONCOGENE (2012)
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
A. L. Smith et al.
ONCOGENE (2012)
The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Human ovarian cancer cell morphology, motility, and proliferation are differentially influenced by autocrine TGFβ superfamily signalling
Brigitte Lise Theriault et al.
CANCER LETTERS (2011)
Kinetic Analysis Reveals the Fate of a MicroRNA following Target Regulation in Mammalian Cells
Alessia Baccarini et al.
CURRENT BIOLOGY (2011)
miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma
Cheng-Chieh Yang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Bogdan Mateescu et al.
NATURE MEDICINE (2011)
The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression
Livia Quattrocchi et al.
VIRCHOWS ARCHIV (2011)
Integrated genomics of chemotherapy resistant ovarian cancer: A role for extracellular matrix, TGFbeta and regulating microRNAs
Jozien Helleman et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Mammalian microRNAs predominantly act to decrease target mRNA levels
Huili Guo et al.
NATURE (2010)
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Li Ma et al.
NATURE BIOTECHNOLOGY (2010)
Identification of MicroRNA-181 by Genome-Wide Screening as a Critical Player in EpCAM-Positive Hepatic Cancer Stem Cells
Junfang Ji et al.
HEPATOLOGY (2009)
Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells
Takeshi Haraguchi et al.
NUCLEIC ACIDS RESEARCH (2009)
Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types
Roy Navon et al.
PLOS ONE (2009)
MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
Nuo Yang et al.
CANCER RESEARCH (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNA expression profiles in serous ovarian carcinoma
Eun Ji Nam et al.
CLINICAL CANCER RESEARCH (2008)
Transforming growth factor-β1, transforming growth factor-β2, and transforming growth factor-β3 enhance ovarian cancer metastatic potential by inducing a smad3-dependent epithelial-to-mesenchymal transition
Thuy-Vy Do et al.
MOLECULAR CANCER RESEARCH (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
Neetu Dahiya et al.
PLOS ONE (2008)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Impaired microRNA processing enhances cellular transformation and tumorigenesis
Madhu S. Kumar et al.
NATURE GENETICS (2007)
KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers
TW Corson et al.
ONCOGENE (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
The role of epithelial-to-mesenchymal transition in renal fibrosis
M Zeisberg et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas
C Faleiro-Rodrigues et al.
ANNALS OF ONCOLOGY (2004)
Borderline ovarian tumors: Diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images
JD Seidman et al.
HUMAN PATHOLOGY (2004)
Share Paper
